Holocene Advisors LP Raises Stake in HCA Healthcare, Inc. (NYSE:HCA)

Holocene Advisors LP boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 210.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 306,796 shares of the company’s stock after buying an additional 208,015 shares during the quarter. Holocene Advisors LP’s holdings in HCA Healthcare were worth $124,691,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. FMR LLC raised its holdings in HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. purchased a new position in HCA Healthcare in the second quarter worth about $131,527,000. Darsana Capital Partners LP increased its holdings in shares of HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares in the last quarter. Argent Capital Management LLC raised its stake in HCA Healthcare by 1,215.6% during the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock worth $51,493,000 after acquiring an additional 148,092 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of HCA Healthcare by 53.5% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 304,819 shares of the company’s stock worth $123,888,000 after purchasing an additional 106,246 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HCA. Barclays dropped their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Morgan Stanley started coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Finally, Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Trading Up 0.1 %

Shares of HCA opened at $327.50 on Monday. The firm’s 50-day moving average is $371.88 and its two-hundred day moving average is $358.84. The firm has a market capitalization of $82.96 billion, a P/E ratio of 14.69, a PEG ratio of 1.26 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $250.67 and a twelve month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,155 shares of company stock worth $5,608,990. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.